{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:44:44Z","timestamp":1740109484059,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00259-019-04459-5","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T07:02:37Z","timestamp":1564556557000},"page":"2220-2222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular imaging of impulse control disorders in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9144-2653","authenticated-orcid":false,"given":"Joonas","family":"Majuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juho","family":"Joutsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"4459_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67:589\u201395. \n                    https:\/\/doi.org\/10.1001\/archneurol.2010.65\n                    \n                  .","journal-title":"Arch Neurol"},{"key":"4459_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/HRP.0000000000000051","volume":"23","author":"YH Yau","year":"2015","unstructured":"Yau YH, Potenza MN. Gambling disorder and other behavioral addictions: recognition and treatment. Harv Rev Psychiatry. 2015;23:134\u201346. \n                    https:\/\/doi.org\/10.1097\/HRP.0000000000000051\n                    \n                  .","journal-title":"Harv Rev Psychiatry"},{"doi-asserted-by":"publisher","unstructured":"Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F, Martin-Bastida A, Botas-Pe\u00f1in A, Jimenez-Urbieta H, et al. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson\u2019s disease patients with impulse control disorders. Eur J Nucl Med Mol Imaging. 2019. \n                    https:\/\/doi.org\/10.1007\/s00259-019-04396-3\n                    \n                  .","key":"4459_CR3","DOI":"10.1007\/s00259-019-04396-3"},{"key":"4459_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3:760\u201373. \n                    https:\/\/doi.org\/10.1016\/S2215-0366(16)00104-8\n                    \n                  .","journal-title":"Lancet Psychiatry"},{"key":"4459_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","volume":"39","author":"R Cilia","year":"2010","unstructured":"Cilia R, Ko JH, Cho SS, van Eimeren T, Marotta G, Pellecchia G, et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling. Neurobiol Dis. 2010;39:98\u2013104. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2010.03.013\n                    \n                  .","journal-title":"Neurobiol Dis"},{"key":"4459_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jnnp-2013-305549","volume":"85","author":"JY Lee","year":"2014","unstructured":"Lee JY, Seo SH, Kim YK, Yoo HB, Kim YE, Song IC, et al. Extrastriatal dopaminergic changes in Parkinson\u2019s disease patients with impulse control disorders. J Neurol Neurosurg Psychiatry. 2014;85:23\u201330. \n                    https:\/\/doi.org\/10.1136\/jnnp-2013-305549\n                    \n                  .","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4459_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","volume":"85","author":"V Voon","year":"2014","unstructured":"Voon V, Rizos A, Chakravartty R, Mulholland N, Robinson S, Howell NA, et al. Impulse control disorders in Parkinson\u2019s disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry. 2014;85:148\u201352. \n                    https:\/\/doi.org\/10.1136\/jnnp-2013-305395\n                    \n                  .","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4459_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, et al. Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2014;29:904\u201311. \n                    https:\/\/doi.org\/10.1002\/mds.25886\n                    \n                  .","journal-title":"Mov Disord"},{"key":"4459_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.parkreldis.2016.05.028","volume":"30","author":"E Premi","year":"2016","unstructured":"Premi E, Pilotto A, Garibotto V, Bigni B, Turrone R, Alberici A, et al. Impulse control disorder in PD: a lateralized monoaminergic frontostriatal disconnection syndrome? Parkinsonism Relat Disord. 2016;30:62\u20136. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2016.05.028\n                    \n                  .","journal-title":"Parkinsonism Relat Disord"},{"key":"4459_CR10","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","volume":"87","author":"KM Smith","year":"2016","unstructured":"Smith KM, Xie SX, Weintraub D. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry. 2016;87:864\u201370. \n                    https:\/\/doi.org\/10.1136\/jnnp-2015-311827\n                    \n                  .","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4459_CR11","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"TD Steeves","year":"2009","unstructured":"Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain. 2009;132:1376\u201385. \n                    https:\/\/doi.org\/10.1093\/brain\/awp054\n                    \n                  .","journal-title":"Brain"},{"key":"4459_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/brain\/awr003","volume":"134","author":"SS O\u2019Sullivan","year":"2011","unstructured":"O\u2019Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, et al. Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours. Brain. 2011;134:969\u201378. \n                    https:\/\/doi.org\/10.1093\/brain\/awr003\n                    \n                  .","journal-title":"Brain"},{"key":"4459_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","volume":"48","author":"NJ Ray","year":"2012","unstructured":"Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, et al. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson\u2019s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis. 2012;48:519\u201325. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2012.06.021\n                    \n                  .","journal-title":"Neurobiol Dis"},{"key":"4459_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/mds.26135","volume":"30","author":"DE Payer","year":"2015","unstructured":"Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, et al. [11C]-(+)-PHNO PET imaging of dopamine D(2\/3) receptors in Parkinson\u2019s disease with impulse control disorders. Mov Disord. 2015;30:160\u20136. \n                    https:\/\/doi.org\/10.1002\/mds.26135.","journal-title":"Mov Disord"},{"key":"4459_CR15","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00415-015-7722-7","volume":"262","author":"K Wu","year":"2015","unstructured":"Wu K, Politis M, O\u2019Sullivan SS, Lawrence AD, Warsi S, Bose S, et al. Single versus multiple impulse control disorders in Parkinson\u2019s disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release. J Neurol. 2015;262:1504\u201314. \n                    https:\/\/doi.org\/10.1007\/s00415-015-7722-7\n                    \n                  .","journal-title":"J Neurol"},{"key":"4459_CR16","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1523\/JNEUROSCI.3082-17.2018","volume":"38","author":"AJ Stark","year":"2018","unstructured":"Stark AJ, Smith CT, Lin YC, Petersen KJ, Trujillo P, van Wouwe NC, et al. Nigrostriatal and mesolimbic D2\/3 receptor expression in Parkinson\u2019s disease patients with compulsive reward-driven behaviors. J Neurosci. 2018;38:3230\u20139. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3082-17.2018\n                    \n                  .","journal-title":"J Neurosci"},{"key":"4459_CR17","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1212\/WNL.0000000000003810","volume":"88","author":"L Saari","year":"2017","unstructured":"Saari L, Kivinen K, Gardberg M, Joutsa J, Noponen T, Kaasinen V. Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease. Neurology. 2017;88:1461\u20137. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003810\n                    \n                  .","journal-title":"Neurology"},{"doi-asserted-by":"publisher","unstructured":"Honkanen EA, Saari L, Orte K, Gardberg M, Noponen T, Joutsa J, et al. No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson\u2019s disease. Mov Disord. 2019. \n                    https:\/\/doi.org\/10.1002\/mds.27777\n                    \n                  .","key":"4459_CR18","DOI":"10.1002\/mds.27777"},{"key":"4459_CR19","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/mds.24941","volume":"27","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Martikainen K, Niemel\u00e4 S, Johansson J, Forsback S, Rinne JO, et al. Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders. Mov Disord. 2012;27:778\u201382. \n                    https:\/\/doi.org\/10.1002\/mds.24941\n                    \n                  .","journal-title":"Mov Disord"},{"key":"4459_CR20","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neuroimage.2012.02.006","volume":"60","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Johansson J, Niemel\u00e4 S, Ollikainen A, Hirvonen MM, Piepponen P, et al. Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage. 2012;60:1992\u20139. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2012.02.006\n                    \n                  .","journal-title":"Neuroimage"},{"key":"4459_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/mp.2013.163","volume":"19","author":"I Boileau","year":"2014","unstructured":"Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, et al. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Mol Psychiatry. 2014;19:1305\u201313. \n                    https:\/\/doi.org\/10.1038\/mp.2013.163\n                    \n                  .","journal-title":"Mol Psychiatry"},{"key":"4459_CR22","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/npp.2016.265","volume":"42","author":"J Majuri","year":"2017","unstructured":"Majuri J, Joutsa J, Johansson J, Voon V, Alakurtti K, Parkkola R, et al. Dopamine and opioid neurotransmission in behavioral addictions: a comparative PET study in pathological gambling and binge eating. Neuropsychopharmacology. 2017;42:1169\u201377. \n                    https:\/\/doi.org\/10.1038\/npp.2016.265\n                    \n                  .","journal-title":"Neuropsychopharmacology"},{"doi-asserted-by":"publisher","unstructured":"Pettorruso M, Martinotti G, Cocciolillo F, De Risio L, Cinquino A, Di Nicola M, et al. Striatal presynaptic dopaminergic dysfunction in gambling disorder: a 123I\u2010FP\u2010CIT SPECT study. Addict Biol. 2018. \n                    https:\/\/doi.org\/10.1111\/adb.12677\n                    \n                  .","key":"4459_CR23","DOI":"10.1111\/adb.12677"},{"key":"4459_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/awz007","volume":"142","author":"J Hammes","year":"2019","unstructured":"Hammes J, Theis H, Giehl K, Hoenig MC, Greuel A, Tittgemeyer M, et al. Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control. Brain. 2019;142:733\u201343. \n                    https:\/\/doi.org\/10.1093\/brain\/awz007\n                    \n                  .","journal-title":"Brain"},{"key":"4459_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","volume":"24","author":"V Voon","year":"2011","unstructured":"Voon V, Mehta AR, Hallett M. Impulse control disorders in Parkinson\u2019s disease: recent advances. Curr Opin Neurol. 2011;24:324\u201330. \n                    https:\/\/doi.org\/10.1097\/WCO.0b013e3283489687\n                    \n                  .","journal-title":"Curr Opin Neurol"},{"key":"4459_CR26","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1073\/pnas.1602413113","volume":"113","author":"A Eklund","year":"2016","unstructured":"Eklund A, Nichols TE, Knutsson H. Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates. Proc Natl Acad Sci U S A. 2016;113:7900\u20135. \n                    https:\/\/doi.org\/10.1073\/pnas.1602413113\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4459_CR27","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1002\/hbm.24068","volume":"39","author":"A Verger","year":"2018","unstructured":"Verger A, Klesse E, Chawki MB, Witjas T, Azulay JP, Eusebio A, et al. Brain PET substrate of impulse control disorders in Parkinson\u2019s disease: a metabolic connectivity study. Hum Brain Mapp. 2018;39:3178\u201386. \n                    https:\/\/doi.org\/10.1002\/hbm.24068\n                    \n                  .","journal-title":"Hum Brain Mapp"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04459-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T23:24:33Z","timestamp":1596065073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04459-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4459"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04459-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"type":"print","value":"1619-7070"},{"type":"electronic","value":"1619-7089"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"17 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Majuri has received a speaker honorarium from Boehringer Ingelheim. Dr. Joutsa has received a grant from the Orion research foundation and taken part in sponsored academic meetings\/seminars.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}